Ovarian Cancer at Johns Hopkins What's New? Resources Ovarian Cancer Community Coping with Ovarian Cancer Clinical Trials
 

You Should Know

Anatomy

Prevention

Risk Factors

Genetics

Screening

CA 125

Symptoms

Early Detection

Diagnosis

Radiology

Pathologists

Staging

Treatment

Recurrent Disease

Recurrent Q & A

Nutrition

Prognosis

Clinical Trials

Glossary

Discussion Board

Questions for Dr.


 
Screening

Screening involves an examination or testing to identify patients with cancer in its early stage (see Staging) before they have symptoms. This is especially relevant to those women with a family history of ovarian cancer. It is particularly important to identify ovarian cancer in its early stages (more info) because treatment is most effective while the disease is confined to the ovaries.

Pelvic examination, particularly when there is persistent abdominal discomfort. Although not routinely performed the following tests are recommended for those women with a family history of ovarian cancer:


These screening procedures are imperfect. There is a critical need for improved screening methods to identify women with early stage ovarian cancer. At Johns Hopkins we have a major research effort devoted to improvement of population screening tests. There is also a large National Cancer Institute-sponsored screening trial ongoing to test the efficacy of CA125 and TVS in screening for early ovarian cancers ( CancerNet's Questions and Answers About the PLCO Cancer Screening Trial).

Article on screening trial and early diagnosis in CAP July 2002.


  
     
HONcode Logo We subscribe to the HONcode principles. Verify

Copyright © 2000-2014 Johns Hopkins University.
All rights reserved.
Disclaimer & Privacy   Last modified July 23, 2003